INTERNATIONAL PATENT: NATIONAL CANCER CENTER, 国立研究開発法人国立がん研究センター, ARC THERAPIES INC., ＡＲＣ　ＴＨＥＲＡＰＩＥＳ株式会社 FILES APPLICATION FOR "SURVIVOR T CELLS, SURVIVOR T CELL POPULATION AND PHARMACEUTICAL COMPOSITION"

Posted On: 2025-07-21

GENEVA, July 21 -- NATIONAL CANCER CENTER (1-1, Tsukiji 5-chome, Chuo-ku, Tokyo1040045), 国立研究開発法人国立がん研究センター (東京都中央区築地五丁目１番１号), ARC THERAPIES INC. (8, Sugamachi, Shinjuku-ku, Tokyo1600018), ＡＲＣ　Ｔｈｅｒａｐｉｅｓ株式会社 (東京都新宿区須賀町８番地) filed a patent application (PCT/JP2025/000412) for "SURVIVOR T CELLS, SURVIVOR T CELL POPULATI...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: NATIONAL CANCER CENTER, 国立研究開発法人国立がん研究センター, ARC THERAPIES INC., ＡＲＣ　ＴＨＥＲＡＰＩＥＳ株式会社 FILES APPLICATION FOR "SURVIVOR T CELLS, SURVIVOR T CELL POPULATION AND PHARMACEUTICAL COMPOSITION"

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: NATIONAL CANCER CENTER, 国立研究開発法人国立がん研究センター, ARC THERAPIES INC., ＡＲＣ ＴＨＥＲＡＰＩＥＳ株式会社 FILES APPLICATION FOR "SURVIVOR T CELLS, SURVIVOR T CELL POPULATION AND PHARMACEUTICAL COMPOSITION"

INTERNATIONAL PATENT: NATIONAL CANCER CENTER, 国立研究開発法人国立がん研究センター, ARC THERAPIES INC., ＡＲＣ　ＴＨＥＲＡＰＩＥＳ株式会社 FILES APPLICATION FOR "SURVIVOR T CELLS, SURVIVOR T CELL POPULATION AND PHARMACEUTICAL COMPOSITION"